Compare XERS & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XERS | IMKTA |
|---|---|---|
| Founded | 2005 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2021 | 1994 |
| Metric | XERS | IMKTA |
|---|---|---|
| Price | $10.51 | $85.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $12.86 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 82.6K |
| Earning Date | 11-05-2026 | 11-25-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | ★ 100.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $49,590,000.00 | ★ $5,334,032,609.00 |
| Revenue This Year | $32.91 | N/A |
| Revenue Next Year | $23.75 | N/A |
| P/E Ratio | ★ N/A | $15.91 |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $5.25 | $67.17 |
| 52 Week High | $10.35 | $95.62 |
| Indicator | XERS | IMKTA |
|---|---|---|
| Relative Strength Index (RSI) | 69.93 | 55.03 |
| Support Level | $7.15 | $82.64 |
| Resistance Level | N/A | $90.01 |
| Average True Range (ATR) | 0.52 | 1.76 |
| MACD | 0.13 | 0.23 |
| Stochastic Oscillator | 99.03 | 61.22 |
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.